Last updated: May 30, 2026
Klaron drug suppliers: Which companies manufacture and supply Klaron (clarithromycin) for pharma and wholesale distribution?
Executive summary: Klaron is a brand name used for clarithromycin in multiple markets. The supplier landscape is split between (1) originator/brand holders and contract manufacturers that produce clarithromycin API and finished dosage forms and (2) wholesale importers/distributors that supply local pharmacies and hospitals. No complete, market-specific supplier list can be produced from the provided input alone.
Who supplies Klaron (clarithromycin) to pharmacies and wholesalers?
Featured answer: Klaron supply typically comes from a combination of local pharmaceutical distributors and registered marketing authorization holders that import or manufacture clarithromycin products under their license.
What “suppliers” means in Klaron distribution
In drug commercial terms, “suppliers” usually maps to:
- Marketing authorization holder (MAH) that is responsible for placing Klaron on the market in a given country
- Manufacturer(s) listed on the product label and regulatory file (finished product)
- API manufacturer(s) supporting clarithromycin supply chain (upstream)
- Local wholesaler/distributor that moves inventory to pharmacies and hospitals
Why supply differs by country
Klaron’s supplier set changes with:
- Regulatory authorization in the destination market
- Importation vs local manufacture
- Tendering structures for hospitals
- Product form factors (tabs, suspensions) and strengths
What companies manufacture Klaron clarithromycin finished product?
Featured answer: The finished-product manufacturer is the company named on the product’s regulatory registration and label for each market, with contract manufacturing common in antibiotics.
Which manufacturing sites usually appear in registrations
Finished-dose suppliers for clarithromycin brands commonly include:
- Established CDMOs that produce antibiotic tablets and suspensions
- Regional generic manufacturers that hold the marketing authorization for a brand-name product
Common distribution footprints
Where Klaron is not locally manufactured, supply typically routes through:
- Importers registered with local medicines authorities
- Wholesalers that handle antibiotic distribution under local controlled logistics rules (where applicable)
Which companies supply clarithromycin API used to make Klaron?
Featured answer: Klaron’s upstream supply chain is clarithromycin API manufacturers plus intermediates producers.
Typical API supply chain pattern
- API is produced by chemical manufacturing firms
- API is then formulated by finished-dose manufacturers under GMP
- The MAH sources supply from approved vendor lists
How API vendor lists impact “supplier” visibility
Public visibility is strongest when:
- The MAH lists manufacturers on the label
- The local regulator publishes manufacturing site information
- The product appears in public tenders and import documentation
What is the Orange Book status of Klaron?
Featured answer: No Orange Book status can be stated because the provided input does not identify the exact US product (NDC/strength/form). Orange Book listings are tied to specific FDA-regulated products.
Which patents protect Klaron in major markets?
Featured answer: Patent protection depends on the active ingredient product, dosage form, and country, and requires identification of the specific Klaron presentation and label (strength and form). The provided input does not specify those elements, so no accurate patent estate can be mapped.
What generic or parallel-import Klaron entry risks exist?
Featured answer: Generic and parallel-import risk depends on:
- Whether the Klaron presentation is marketed with exclusivity or branded manufacturing constraints
- Whether local regulatory pathways allow substitution
- The availability of equivalent clarithromycin strengths and dosage forms
How does Klaron supplier coverage compare with other clarithromycin brands?
Featured answer: In most markets, clarithromycin brands share overlapping supplier networks because API and finished-dose manufacturing ecosystems overlap. Exact comparison requires country and product identification.
What regulatory approvals and import requirements determine Klaron suppliers?
Featured answer: Suppliers are determined by:
- Medicines authority approval for marketing authorization
- GMP compliance for manufacturing and import release
- Local labeling and pharmacovigilance obligations
What typically governs eligibility
- GMP manufacturing certificates (API and finished product)
- Product dossier acceptance for that country
- Registration of manufacturing sites and batch release responsibilities
Key Takeaways
- Klaron is a clarithromycin brand name, but supplier lists are country- and presentation-specific.
- “Suppliers” can refer to MAHs, finished-dose manufacturers, API suppliers, and local wholesalers, which are not interchangeable.
- With only “klaron” as input and no market/dose/form identifiers, a complete, accurate supplier roster cannot be produced.
FAQs
- How do I find the manufacturer listed for a specific Klaron strength and dosage form?
- Which documents show the Klaron marketing authorization holder in a given country?
- How can API sourcing affect clarithromycin brand supply continuity during shortages?
- What is the typical path from MAH to hospital procurement for clarithromycin brands like Klaron?
- Do parallel imports change who “supplies” Klaron at the pharmacy level?
References
- (No citable sources provided in the input.)
